EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Novel Anti-Melanoma Compounds Are Efficacious in A375 Cell Line Xenograft Melanoma Model in Nude Mice

Sadeeshkumar Velayutham, Ryan Seerattan, Maab Sultan, Trisha Seal, Samaya Danthurthy, Baskaran Chinnappan, Jessica Landi, Kaitlyn Pearl, Aveta Singh, Keiran S M Smalley, Julia Zaias, Jun Yong Choi iD und 1 weitere

Biomolecules · 2023

DOI: 10.3390/biom13091276 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomolecules, 2023. Verfasst von Sadeeshkumar Velayutham und 12 weiteren Autor:innen. Beteiligte Einrichtung: College of Pharmacy, Nova Southeastern University, 3321 College Avenue, Fort Lauderdale, FL 33314, USA. Hauptthemen laut MEDLINE: Melanoma. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, NIGMS NIH HHS, NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Despite the successes of immunotherapy, melanoma remains one of the deadliest cancers, therefore, the need for innovation remains high. We previously reported anti-melanoma compounds that work by downregulating spliceosomal proteins hnRNPH1 and H2. In a separate study, we reported that these compounds were non-toxic to Balb/C mice at 50 mg/kg suggesting their utility in in vivo studies. In the present study, we aimed to assess the efficacy of these compounds by testing them in A375 cell-line xenograft in nude athymic mice. Animals were randomized into four groups (n = 12/group): 10 mg/kg vemurafenib, and 25 mg/kg 2155-14 and 2155-18 thrice a week for 15 days along with a control group. The results revealed that both 2155-14 and 2155-18 significantly decreased the growth of A375 tumors, which was comparable to vemurafenib. These results were confirmed by tumor volume, weight, and histopathological examination. In conclusion, these results demonstrate the therapeutic potential of targeting spliceosomal proteins hnRNPH1 and H2.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MelanomaMiceAnimalsHumansVemurafenibMice, NudeHeterograftsCell Line, TumorXenograft Model Antitumor AssaysCell Proliferation

Stichwörter der Autor:innen

BRAFcell line xenograftdrug discoverymelanomaorgan histopathologyspliceosomal inhibition

Substanzen

Vemurafenib

Autor:innen und Institutionen

  • College of Pharmacy, Nova Southeastern University, 3321 College Avenue, Fort Lauderdale, FL 33314, USA.
  • Rumbaugh-Goodwin Institute for Cancer Research, Nova Southeastern University, 3321 College Avenue, CCR r.605, Fort Lauderdale, FL 33314, USA.
  • Department of Chemistry and Biochemistry, Queens College, 65-30 Kissena Boulevard, Flushing, NY 11367, USA.
  • Halmos College of Arts and Sciences, Nova Southeastern University, 3301 College Avenue, Fort Lauderdale, FL 33314, USA.
  • Honors College, Nova Southeastern University, 8000 N Ocean Dr., Dania Beach, FL 33004, USA.
  • Dr. Kiran C. Patel College of Osteopathic Medicine, Nova Southeastern University, 3321 College Avenue, Fort Lauderdale, FL 33314, USA.

ORCID-Profile: Jun Yong Choi

Förderung

  • NCI NIH HHS
  • NIGMS NIH HHS
  • NIH HHS
  • NIH
  • NIH SC2 award

Zitieren

APA

Velayutham, S., Seerattan, R., Sultan, M., Seal, T., Danthurthy, S., Chinnappan, B., Landi, J., Pearl, K., Singh, A., Smalley, K. S. M., Zaias, J., Choi, J. Y., & Minond, D. (2023). Novel Anti-Melanoma Compounds Are Efficacious in A375 Cell Line Xenograft Melanoma Model in Nude Mice. Biomolecules. https://doi.org/10.3390/biom13091276

Vancouver

Velayutham S, Seerattan R, Sultan M, Seal T, Danthurthy S, Chinnappan B, et al. Novel Anti-Melanoma Compounds Are Efficacious in A375 Cell Line Xenograft Melanoma Model in Nude Mice. Biomolecules. 2023. doi:10.3390/biom13091276

BibTeX
@article{Velayutham2023,
  author = {Velayutham, Sadeeshkumar and Seerattan, Ryan and Sultan, Maab and Seal, Trisha and Danthurthy, Samaya and Chinnappan, Baskaran and Landi, Jessica and Pearl, Kaitlyn and Singh, Aveta and Smalley, Keiran S M and Zaias, Julia and Choi, Jun Yong and Minond, Dmitriy},
  title = {Novel Anti-Melanoma Compounds Are Efficacious in A375 Cell Line Xenograft Melanoma Model in Nude Mice},
  journal = {Biomolecules},
  year = {2023},
  doi = {10.3390/biom13091276}
}
Kostenlos starten →